Skip to content
OpenCapital
Get started

Design Therapeutics, Inc. DSGN Q1 2026 earnings

Reported April 28, 2026 · Before market open

Revenue-
EPS-$0.29Beat by $0.07
EPS estimate-$0.36

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$0.36

Financials

Q1 2026

Income statement

See full
Revenue-—
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$741.99M+224%
Enterprise value$731.95M+246%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0×0.0×
Current ratio22.3×-6.1×

Versus estimates

Diluted EPS

Q1 2026-$0.29Beat by $0.07
Q4 2025-$0.27Beat by $0.11Q3 2025-$0.30Beat by $0.04Q2 2025-$0.34Miss by $0.02Q1 2025-$0.31Miss by $0.03Q4 2024-$0.24Beat by $0.04

Ask the moment Design Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Design Therapeutics, Inc. report Q1 2026 earnings?
Design Therapeutics, Inc. (DSGN) reported Q1 2026 earnings on April 28, 2026 before market open.
What were Design Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Design Therapeutics, Inc. reported revenue of - and eps of $-0.29 for Q1 2026.
Did Design Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.36 by $0.07.
How did Design Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 6.5% from $-0.31.
Where can I find Design Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-187012) and the 10-Q periodic report (0001193125-26-187063) directly on SEC EDGAR. The filing index links above go to sec.gov.